EUVIMEDEUVIMED entdecken
Vergleichsstudie

Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran

Abdulkadir Yilmaz, Dogan Emre Sert, Sinan Sabit Kocabeyoglu, Emrah Uguz, Enis Burak Gül, Bekir Boğaçhan Akkaya, Umit Kervan, Zeki Catav

Cardiovascular Journal of Africa · 03.07.2026 · 37 (3) · 253-258

DOI: 10.5830/cvja-2026-015 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cardiovascular Journal of Africa, online erschienen am 03.07.2026. Verfasst von Abdulkadir Yilmaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Bilkent City Hospital, Department of Cardiovascular Surgery, Ankara, Turkey. Hauptthemen laut MEDLINE: Rivaroxaban, Dabigatran, Thiazoles, Factor Xa Inhibitors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RivaroxabanDabigatranThiazolesFactor Xa InhibitorsVenous ThromboembolismPyridinesVenous ThrombosisPyrazolesPyridonesPulmonary EmbolismAntithrombinsHumansFemaleMaleTreatment OutcomeAdministration, OralMiddle AgedHemorrhageAgedRisk FactorsTime FactorsRecurrenceAdultAged, 80 and over

Stichwörter der Autor:innen

apixabandabigatrandeep vein thrombosisdirect oral anticoagulantsedoxabanrivaroxaban

Substanzen

RivaroxabanDabigatranThiazolesedoxabanFactor Xa InhibitorsPyridinesapixabanPyrazolesPyridonesAntithrombins

Autor:innen und Institutionen

  • Ankara Bilkent City Hospital, Department of Cardiovascular Surgery, Ankara, Turkey.
  • Yıldırım Beyazıt University Faculty of Medicine, Department of Cardiovascular Surgery, Ankara, Turkey.
  • Ankara Bilkent City Hospital, Department of Cardiovascular Surgery, Ankara, Turkey. Email: enisburakgul@gmail.com.

Zitieren

APA

Yilmaz, A., Sert, D. E., Kocabeyoglu, S. S., Uguz, E., Gül, E. B., Akkaya, B. B., Kervan, U., & Catav, Z. (2026). Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran. Cardiovascular Journal of Africa, 37(3), 253-258. https://doi.org/10.5830/cvja-2026-015

Vancouver

Yilmaz A, Sert DE, Kocabeyoglu SS, Uguz E, Gül EB, Akkaya BB, et al. Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran. Cardiovascular Journal of Africa. 2026;37(3):253-258. doi:10.5830/cvja-2026-015

BibTeX
@article{Yilmaz2026,
  author = {Yilmaz, Abdulkadir and Sert, Dogan Emre and Kocabeyoglu, Sinan Sabit and Uguz, Emrah and Gül, Enis Burak and Akkaya, Bekir Boğaçhan and Kervan, Umit and Catav, Zeki},
  title = {Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran},
  journal = {Cardiovascular Journal of Africa},
  year = {2026},
  volume = {37},
  number = {3},
  pages = {253--258},
  doi = {10.5830/cvja-2026-015}
}
Kostenlos starten →